Verve Therapeutics
VERV
#7356
Rank
โ‚ฌ0.31 B
Marketcap
3,60ย โ‚ฌ
Share price
-5.44%
Change (1 day)
-69.77%
Change (1 year)

Revenue for Verve Therapeutics (VERV)

Revenue in 2024 (TTM): โ‚ฌ30.23 Million

According to Verve Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ29.78 Million. an increase over the revenue in the year 2023 that were of โ‚ฌ10.63 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Verve Therapeutics from 2020 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ31.07 M192.11%
2023 โ‚ฌ10.63 M487.8%
2022 โ‚ฌ1.8 M
2021 N/A
2020 N/A